Mumbai — The promoter entities of the Jubilant Group, a diversified Indian conglomerate with interests spanning food service, pharmaceuticals, and life sciences, have collectively sold shares worth ₹1,801 crore across three group companies — Jubilant FoodWorks, Jubilant Ingrevia, and Jubilant Pharmova — through open market transactions on Friday.
Block Deal Summary:
According to data from the National Stock Exchange (NSE):
-
Jubilant Consumer, a promoter entity of Jubilant FoodWorks Ltd (JFL), sold 1.06 crore equity shares, amounting to a 1.61% stake in the company.
-
In Jubilant Ingrevia, three promoter entities — Jubilant Enpro, Nikita Resources, and Shyam Sunder Bhartia Family Trust — offloaded a combined 98.65 lakh shares, representing a 6.2% stake.
-
For Jubilant Pharmova, promoters Jubilant Enpro and Nikita Resources sold 32.86 lakh shares, equating to a 2.06% stake in the firm.
The share sales were executed in the price range of ₹662 to ₹1,060.37 per share, taking the cumulative deal value to approximately ₹1,800.98 crore.
Post-Transaction Shareholding:
-
The promoter holding in Jubilant FoodWorks decreased from 41.94% to 40.33%.
-
In Jubilant Ingrevia, the promoter stake was reduced from 51.47% to 45.27%.
-
Jubilant Pharmova’s promoter shareholding dropped from 50.68% to 48.12%.
Market Reaction:
-
Jubilant Ingrevia shares surged 15.09% to close at ₹784.90.
-
Jubilant FoodWorks gained 2.12%, settling at ₹682.
-
However, Jubilant Pharmova slipped 2.97% to ₹1,092.20 per share on the NSE.
Institutional Buyers Participate Aggressively:
Several marquee institutional investors participated in the deals, including:
-
Societe Generale
-
Morgan Stanley
-
Kotak Mahindra Mutual Fund
-
ICICI Prudential Life Insurance
-
Bandhan Mutual Fund
-
Axis Mutual Fund
-
HDFC Mutual Fund
-
Bajaj Allianz Life Insurance
-
Alberta Investment Management Corporation (AIMCo) — a leading Canadian pension fund
Notably, Kotak Mahindra Mutual Fund acquired the full 2.06% stake in Jubilant Pharmova that was offloaded by the promoters. Details regarding other buyers of Jubilant Pharmova shares were not immediately available.
Strategic Context & Analyst View:
While the company has not disclosed reasons for the stake sale, analysts view the transactions as part of strategic capital reallocation by the promoters. The Jubilant Group has been actively reshaping its portfolio across verticals including QSR (Quick Service Restaurants), pharmaceuticals, specialty chemicals, and life sciences.
Despite the sizable promoter sell-off, investor response remained largely positive, especially for Jubilant Ingrevia and Jubilant FoodWorks, suggesting confidence in the group’s long-term fundamentals.